Stephanie Louise Gaillard MD
Hematologic Oncology
Assistant Professor of Medicine, Duke University School of Medicine
Join to View Full Profile
10803 Falls RoadPavilion III STE 1500Lutherville, MD 21093
Phone+1 410-583-2970
Fax+1 410-583-2980
Dr. Gaillard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
Duke University School of MedicineClass of 2006
Certifications & Licensure
MD State Medical License 2009 - 2026
PA State Medical License 2020 - 2022
NC State Medical License 2012 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Start of enrollment: 2013 Feb 01
- Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA Start of enrollment: 2014 Sep 01
- A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.Robert L Hollis, Austin Miller, Heather A Lankes, Kwong-Kwok Wong, William Rodgers
Clinical Cancer Research. 2026-02-17 - 1 citationsCervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.Nadeem R Abu-Rustum, Susana M Campos, Sudha Amarnath, Rebecca Arend, Emma Barber
Journal of the National Comprehensive Cancer Network. 2025-12-01 - 1 citationsEvaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability.Bradley R Corr, Samantha M Thomas, Paulina J Haight, Elizabeth Stock, Jessica Floyd
Gynecologic Oncology. 2025-10-01
Journal Articles
- T Cell-Inflamed Phenotype and Increased Foxp3 Expression in Infiltrating T-cells of Mismatch-Repair Deficient Endometrial CancersStephanie Gaillard, MD, Nature
Press Mentions
ASCO Updates Treatment Guidance for Newly Diagnosed, Advanced Ovarian CancerFebruary 24th, 2025- Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual MeetingMay 26th, 2023
- Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer FoundationApril 26th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
